Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

BACKGROUND: Non-invasive tests are widely used to diagnose fibrosis in patients with non-alcoholic fatty liver disease (NAFLD), however, the optimal method remains unclear. We compared the accuracy of simple serum models, a serum model incorporating direct measures of fibrogenesis (Hepascore), and F...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertot, Luis C., Jeffrey, Gary P., de Boer, Bastiaan, Wang, Zhengyi, Huang, Yi, Garas, George, MacQuillan, Gerry, Wallace, Michael, Smith, Briohny W., Adams, Leon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188580/
https://www.ncbi.nlm.nih.gov/pubmed/36947289
http://dx.doi.org/10.1007/s10620-023-07896-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188580/
https://www.ncbi.nlm.nih.gov/pubmed/36947289
http://dx.doi.org/10.1007/s10620-023-07896-3

Ejemplares similares